Urinary biomarkers like Urinary Insulin-Like Growth Factor-Binding Protein 7 (IGFBp7) and urinary Tissue Inhibitor of Matrix Metalloproteinase 2 (TIMP2) have emerged as potential tools for identifying renal impairment in MM [14]. The gene discussed is IGFBP7; the disease is Miyoshi myopathy.